<DOC>
	<DOCNO>NCT01315457</DOCNO>
	<brief_summary>The aim study propose infection prophylaxis Asian multinational retrospective analysis infectious complication patient treat alemtuzumab</brief_summary>
	<brief_title>Infections Associated With Use Alemtuzumab</brief_title>
	<detailed_description />
	<mesh_term>Alemtuzumab</mesh_term>
	<criteria>Patients receive alemtuzumab treatment hematologic malignancy ex . nonHodgkin lymphoma Acute myeloid leukemia Aplastic anemia Patients receive alemtuzumab</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>alemtuzumab , infection , prophylaxis , treatment</keyword>
</DOC>